LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 8.76 | 27.76 | 5 | 401 | 0.0125 | -0.3591 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 8.76 | 27.76 | 921 | 401 | 2.2959 | 1.4815 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 10.46 | 27.76 | 1 | 438 | 0.0023 | -0.5660 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 10.46 | 27.76 | 874 | 438 | 1.9925 | 1.3780 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 10.46 | 27.76 | 5 | 438 | 0.0114 | -0.3498 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 10.46 | 27.76 | 934 | 438 | 2.1293 | 1.4180 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 12.17 | 27.76 | 1 | 489 | 0.0020 | -0.5520 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 12.17 | 27.76 | 904 | 489 | 1.8484 | 1.3200 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 12.17 | 27.76 | 10 | 489 | 0.0204 | -0.2186 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 12.17 | 27.76 | 967 | 489 | 1.9772 | 1.3581 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 13.87 | 27.76 | 1 | 604 | 0.0017 | -0.5265 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 13.87 | 27.76 | 1038 | 604 | 1.7165 | 1.2585 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 13.87 | 27.76 | 13 | 604 | 0.0215 | -0.1569 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 13.87 | 27.76 | 1020 | 604 | 1.6867 | 1.2496 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 15.58 | 27.76 | 1 | 685 | 0.0015 | -0.5125 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 15.58 | 27.76 | 1006 | 685 | 1.4674 | 1.1728 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 15.58 | 27.76 | 17 | 685 | 0.0248 | -0.1006 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 15.58 | 27.76 | 1126 | 685 | 1.6424 | 1.2264 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 17.28 | 27.76 | 1 | 838 | 0.0012 | -0.4913 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 17.28 | 27.76 | 1031 | 838 | 1.2293 | 1.0857 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 17.28 | 27.76 | 27 | 838 | 0.0322 | -0.0056 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 17.28 | 27.76 | 1008 | 838 | 1.2018 | 1.0762 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 18.98 | 27.76 | 1 | 941 | 0.0011 | -0.4799 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 18.98 | 27.76 | 1021 | 941 | 1.0849 | 1.0323 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 18.98 | 27.76 | 37 | 941 | 0.0393 | 0.0582 | MN20160318_Q01 | K13 |